ConductScience.org, home

Paper32216675

Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not?.

Xiaoyu P and 3 others. Gut Microbes, 2020. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not?. Papers, record 32216675. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32216675

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not?.
PubMed
Journal
Gut Microbes
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.41
iCite
Revised in PubMed
2024-03-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial Physiological PhenomenaMajor topic
Gastrointestinal MicrobiomeMajor topic
Gastrointestinal TractMajor topic
Immune Checkpoint InhibitorsMajor topic
ImmunotherapyMajor topic
NeoplasmsMajor topic
Animals
Bacteria
Biomarkers
Feces
Humans
Immunity
Symbiosis

Source PubMed

Download CSV of topics

References113

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127911839Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/27911839PubMed
225846071Effects of Bifidobacterium supplementation on intestinal microbiota composition and the immune response in healthy infants.World J Pediatr2016https://conductscience.org/library/papers/25846071PubMed
329782924Emerging biomarkers for immune checkpoint inhibition in lung cancer.Semin Cancer Biol2018https://conductscience.org/library/papers/29782924PubMed
424566914Intestinal epithelial cells: regulators of barrier function and immune homeostasis.Nat Rev Immunol2014https://conductscience.org/library/papers/24566914PubMed
527892954A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.Nat Med2017https://conductscience.org/library/papers/27892954PubMed
629567829The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.Cancer Discov2018https://conductscience.org/library/papers/29567829PubMed
731194939Daily Sampling Reveals Personalized Diet-Microbiome Associations in Humans.Cell Host Microbe2019https://conductscience.org/library/papers/31194939PubMed
821747801Environmental and gut bacteroidetes: the food connection.Front Microbiol2011https://conductscience.org/library/papers/21747801PubMed
918854238Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine.Cell Host Microbe2008https://conductscience.org/library/papers/18854238PubMed
1028167454Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients.Eur J Cancer2017https://conductscience.org/library/papers/28167454PubMed
1127571978The microenvironment of injured murine gut elicits a local pro-restitutive microbiota.Nat Microbiol2016https://conductscience.org/library/papers/27571978PubMed
1227446020Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut.Front Microbiol2016https://conductscience.org/library/papers/27446020PubMed
1325841013Anoxic Conditions Promote Species-Specific Mutualism between Gut Microbes In Silico.Appl Environ Microbiol2015https://conductscience.org/library/papers/25841013PubMed
1426749362Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer.J Gastroenterol2016https://conductscience.org/library/papers/26749362PubMed
1531398337Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.Cell2019https://conductscience.org/library/papers/31398337PubMed
1630684593Gut microbiome and cancer immunotherapy.Cancer Lett2019https://conductscience.org/library/papers/30684593PubMed
1729042691Gastric cancer: The gastric microbiota - bacterial diversity and implications.Nat Rev Gastroenterol Hepatol2017https://conductscience.org/library/papers/29042691PubMed
1827231050Gut microbiota, metabolites and host immunity.Nat Rev Immunol2016https://conductscience.org/library/papers/27231050PubMed
1929610286Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling.Cancer Discov2018https://conductscience.org/library/papers/29610286PubMed
2030121899Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism.Cancer Immunol Immunother2018https://conductscience.org/library/papers/30121899PubMed

See all 113 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42490947Microbiome and cancer: mechanistic insights, diagnostic potential, and therapeutic strategies.Front Cell Dev Biol2026https://conductscience.org/library/papers/42490947PubMed
41564102Fecal microbiota transplantation ameliorates radiation-induced lung injury by reshaping gut metabolic homeostasis to activate FAM134B-mediated ER-phagy.PLoS Pathog2026https://conductscience.org/library/papers/41564102PubMed
41007735The Gut-Brain Axis in Brain Tumors: Insights into Tumor Development, Progression, and Therapy.Biomedicines2025https://conductscience.org/library/papers/41007735PubMed
40487934Diagnostic value of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in serum, bile, and feces in hepatocellular carcinoma.World J Gastrointest Oncol2025https://conductscience.org/library/papers/40487934PubMed
40333213Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges.Vaccines (Basel)2025https://conductscience.org/library/papers/40333213PubMed
40116116Advances in research on the intestinal microbiota in the mechanism and prevention of colorectal cancer (Review).Mol Med Rep2025https://conductscience.org/library/papers/40116116PubMed
34485534The Role of Gut Microbiota in Tumor Immunotherapy.J Immunol Res2021https://conductscience.org/library/papers/34485534PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32216675

GET https://conductscience.org/api/papers/v1/32216675/references?page=2